Investigation of the Effects of Family-Focused Therapy in the Early Period of Bipolar Disorder and Psychotic Disorder
1 other identifier
interventional
20
1 country
1
Brief Summary
Family-focused therapy (FFT) is a comprehensive therapy approach applied to individuals and their families. In the present study, the researchers aimed to investigate the effects of family-focused therapy (FFT) in the early stages of psychotic disorder and bipolar disorder, regarding the psychiatric symptomatology, family communication skills, coping capacities, family burden and quality of life. A total of 34 young people diagnosed with bipolar disorder (BD) and 17 psychotic disorders (PD) will be included in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 27, 2023
CompletedFirst Posted
Study publicly available on registry
April 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJune 11, 2024
June 1, 2024
1.5 years
March 27, 2023
June 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
The change from baseline to follow-up in Hamilton Depression Rating Scale (HDRS) scores
by independent clinician/ to the patient - HDRS is a clinician-administered scale that measures the severity of depression. It contains 17 questions scored between 0-4. The total score of the scale ranges from 0 to 51. Cut-off points were determined as \<7 normal, 8-13 mild, 14-18 moderate, 19-22 severe and \>23 very severe.
at baseline and at week 9
The change from baseline in Young Mania Rating Scale score
by independent clinician/ to the patient - The Young Mania Rating Scale (YMRS) is a likert-type scale developed to measure the severity of manic symptoms. 7 of 11 items are graded in the range of 0-4, and the other 4 items are graded in the range of 0-8 points. Therapy sessions will be started if the Young Mania Rating Scale total score is ≤ 14 points. In addition, measurements will be repeated at the end of therapy.
at baseline and at week 9
The change from baseline in Scale for the Assessment of Positive Symptoms (SAPS)
by independent clinician/ to the patient - This scale aims to measure severity of positive symptoms in schizophrenia. It includes a total of 34 items in 4 subscales: hallucinations, delusions, bizarre behavior and positive formal thought disorder. Measurements will be made at the beginning and the difference will be examined by repeating at the end of the sessions.
at baseline and at week 9
The change from baseline in Brief Negative Symptom Scale (BNSS)
by independent clinician/ to the patient - BNSS consists of 13 items and has six subscales: anhedonia, stress, asociality, avolition, blunt affectivity, and alogia. The total score of the scale, which can range from 0 to 78, is obtained by summing the scores of 13 items. Measurements will be made at the beginning and the difference will be examined by repeating at the end of the sessions.
at baseline and at week 9
The change from Personal and Social Performance Scale (PSP) scores
by independent clinician/ to the patient - The scale evaluates personal and social performance in 4 sub-dimensions; Socially useful activities, personal and social relationships, self-care, irritating and aggressive behavior. 6-point Likert-type rating (1=absent - 6=very severe) was used.
at baseline and at week 9
The change from Scale of Unawareness of Mental Disorder (SUMD) scores
by independent clinician/ to the patient - SUMD was developed by Amador et al in 1993 to evaluate insight in psychiatric disorders. The Turkish reliability of this scale was determined by Bora E et al. (Bora et al. 2006). The scale is scored between 1-5 points and consists of 3 general items: being aware of mental disorders, being aware of the effects of drugs, and being aware of the social consequences of the disorder. High scores represent poor insight.
at baseline and at week 9
Secondary Outcomes (6)
Coping Strategies Scale Brief Form (Brief COPE)
at baseline and at week 9
Shortened Level of Expressed Emotion Scale
at baseline and at week 9
World Health Organization Quality of Life Assessment (WHOQOL)
at baseline and at week 9
Mc Master Family Assessment Device
at baseline and at week 9
Beck's Depression Inventory
at baseline and at week 9
- +1 more secondary outcomes
Study Arms (1)
Family-Focused Therapy
EXPERIMENTALBipolar Disorder and Psychotic Disorder
Interventions
After the patient and family are informed, they are included in the therapy group on a voluntary basis. After evaluation by independent evaluators, therapy sessions are started by therapists. Session 1: Goal Setting, Treatment Overview, Symptoms, Vulnerability Stress Model Session 2: Stress and Coping Skills, Regulation of sleep habits, Relaxation exercises Session 3: Optimizing Family Support; Prevention Plan, Medication adherence Session 4: Overview of Communication Skills; Expressing Positive Feelings, Active Listening Session 5: Making Positive Requests for Change, Communication Clarity Session 6: Expressing Negative Feelings Session 7: Introduction to Problem Solving Skills Session 8 and 9: Problem Solving Skills, Termination of Treatment The same psychometric assessment will be repeated before and after FFT. Intra-group comparisons will be made. Also study groups will be compared using time by group interactions to investigate the differences in therapy response.
Eligibility Criteria
You may qualify if:
- Not be in an active phase of the illness
- Able to comply with the interviews
- The total score of the Hamilton Depression Rating Scale ≤ 21 points.
- The total score of the Young Mania Rating Scale ≤ 14 points.
- At least one family member with the capacity to read and write in Turkish
You may not qualify if:
- Neurological disorders and serious physical disease that affect cognitive functions
- The symptoms due to substance use or a medical illness
- Autism Spectrum Disorder
- Comorbid alcohol and substance abuse (except nicotine)
- Co-morbid psychiatric disorders except disruptive behavior disorders and anxiety disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dokuz Eylül University
Izmir, Balcova, 35330, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Neslihan Inal, M.D.
Dokuz Eylul University Department of Child and Adolescent Psychiatry
- STUDY DIRECTOR
Emre Bora, M.D.
Dokuz Eylul University Department of Psychiatry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Department of Child and Adolescent Psychiatry
Study Record Dates
First Submitted
March 27, 2023
First Posted
April 12, 2023
Study Start
April 1, 2022
Primary Completion
October 1, 2023
Study Completion
December 31, 2023
Last Updated
June 11, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share